Quanterix and Innovita win China approval for Alzheimer's blood tests

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/22/2026

1. META
2. TSLA
3. IBM
4. TXN
5. SAP
6. CSX
7. LRCX
8. LVS
9. KNX
10. KMI

Go back to Quanterix and Innovita win China approval for Alzheimer's blood tests

Quanterix and Innovita Expand IVD Access in China with National Medical Products Administration Approvals

October 7, 2026 8:00 AM EDT

NMPA approvals for Quanterix SIMOA® instruments and key neurology biomarker assays advance access to ultra-sensitive blood-based testing in China

BILLERICA, Mass. & BEIJING--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a global leader in precision biomarker science, and Innovita Biological Technology Co., Ltd. (SSE: 688253.SH), a leading in vitro diagnostics company in China, today announced regulatory approvals that advance access to the Quanterix SIMOA® technology and neurology biomarker testing in the Chinese market.

Initially formed in 2024, the commercialization arrangement combines Quanterixs ultra-sensitive biomarker detection technology with Innovitas diagnostics development,... More